Skip to Content
Merck
CN
All Photos(1)

Documents

G005696

LC/MS Analysis of Erythromycin Analogs on Ascentis® Express HILIC

application for HPLC

Sign Into View Organizational & Contract Pricing

technique(s)

HPLC: suitable

test parameters

column: Ascentis Express HILlC, 15 cm x 4.6 mm I.D., 2.7 μm particles (53981-U)
mobile phase: [A] 100 mM ammonium formate, pH 3.0 (titrated with formic acid); [B] acetonitrile; (10:90, A:B)
flow rate: 1.0 mL/min
pressure: 1247 psi (86 bar)
column temp.: 35 °C
detector: ESI(+); SIR
injection: 5 μL

suitability

application for HPLC

application(s)

pharmaceutical (small molecule)

Analysis Note

This application shows the suitability of Ascentis Express Silica columns for the analysis of erythromycin analogs in aqueous normal phase/HILIC mode of chromatography. Other relatively hydrophobic aminoglycosides have also been shown to separate under these conditions.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description

    Erythromycin ethyl succinate
    Erythromycin estolate
    Erythromycin

mobile phase component


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service